Figure 1 PCI strategies in patients with STEMI and multivessel disease

Slides:



Advertisements
Similar presentations
The EMERALD Trial Diabetic Substudy. EMERALD Diabetic Analysis To compare myocardial perfusion and infarct sizes in diabetic and non-diabetic patients.
Advertisements

FRACTIONAL FLOW RESERVE versus ANGIOGRAPHY
To stent or not to stent Clinical Utility of Fractional Flow Reserve.
Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularization versus conservative strategy. PRAGUE 13 trial O.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
Partner meeting Aprile, Alberto Cremonesi.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
Dr.Ali Eshraghi MD Interventional Cardiologist Non STE ACS  Angiographic Findings: 34% 3VD 28%2VD 26%SVD 10%LMCAD Culprit lesion charactristic: eccentric,scalloped,evidence.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2007 Focused Update of the ACC/AHA 2004 Guidelines.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comprehensive Meta-Analysis of Safety and Efficacy.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Correlates of Drug-Eluting Stent Thrombosis.
The American College of Cardiology Presented by Dr. Adnan Kastrati
Copyright © 2005 American Medical Association. All rights reserved.
Impella 2.5® Device Is Associated with Improved Survival in AMICS
Fractional Flow Reserve Workshop
Volume 84, Issue 2, Pages (August 2013)
Figure 4 Pharmacodynamic comparison of crushed versus integral
Figure 4 BMI and mortality in patients with heart failure
Nat. Rev. Cardiol. doi: /nrcardio
Giuseppe Biondi Zoccai
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
Nat. Rev. Cardiol. doi: /nrcardio
Angiography-guided PCI
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial
Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 Imaging in patients with suspected acute coronary syndrome
Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.
European Society of Cardiology 2003
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Ischaemic and bleeding outcomes in the major clinical trials
Nat. Rev. Cardiol. doi: /nrcardio
Bjarne L. Nørgaard et al. JACC 2018;72:
Nat. Rev. Cardiol. doi: /nrcardio
Published in the European Heart Journal
TRIAL HIGHLIGHT FROM ESC 2016: ACUTE CORONARY SYNDROMES
Figure 1 Manual thrombus aspiration
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Milestones in coronary angioplasty
Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 Observational studies on multiple treatment strategies
Mancini JG, et al. Am J Cardiol.
Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.
Figure 1 Ischaemic conditioning
Measure-specific reasons for exclusion (2010-Q4–2013-Q3).
Nat. Rev. Cardiol. doi: /nrcardio
National Trends in the Incidence, Management, and Outcomes of Heart Failure Complications in Patients Hospitalized for ST-Segment Elevation Myocardial.
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Flow chart of the Jakarta Cardiovascular Care Unit (CCU) Network System. Flow chart of the Jakarta Cardiovascular Care Unit (CCU) Network System. There.
Nat. Rev. Cardiol. doi: /nrcardio
European Heart Journal Advance Access
Nat. Rev. Cardiol. doi: /nrcardio
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
From Primary to Secondary Percutaneous Coronary Intervention: The Emerging Concept of Early Mechanical Reperfusion With Delayed Facilitated Stenting—When.
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Figure 1 Design of trials included in individual patient data meta-analysis. Unless provided in the caption above, the following copyright applies to the.
MRRs and EMRRs for women with ACS
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.
Figure 1 Imaging assessments of luminal stenosis, haemodynamic
FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Presentation transcript:

Figure 1 PCI strategies in patients with STEMI and multivessel disease Figure 1 | PCI strategies in patients with STEMI and multivessel disease. In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, primary percutaneous coronary intervention (PCI) for the culprit lesion is followed by evaluation of the severity of nonculprit lesions with the use of either visual estimation only or with additional fractional flow reserve (FFR) measurement during angiography. Treatment options for clinically significant nonculprit lesions include: multivessel primary PCI at the time of the index procedure, planned staged PCI either early (during the initial hospitalization) or late (after discharge), staged PCI if evidence exists of ischaemia on routine noninvasive stress testing, or optimal medical therapy alone. In case of a conservative approach with medical therapy only, the patient has to be re-evaluated when clinical symptoms reoccur. Vogel, B. et al. (2017) Reperfusion strategies in acute myocardial infarction and multivessel disease Nat. Rev. Cardiol. doi:10.1038/nrcardio.2017.88